The purpose of this study is to test the feasibility and safety of early cessation of tacrolimus following allogeneic hematopoietic cell transplantation (HCT).…

GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more

~Estimated

~$10 – $6,250

Stanford UniversityNCT07302776

Phase 1

A Phase I Study to Evaluate the Safety and Maximum Tolerated Dose of Momelotinib Durind and Following Hematopoietic Cell Transplantation for Patients With Myelofibrosis

This is a single-center, open-label, phase I study to determine the safety and tolerability of momelotinib in patients with myelofibrosis during and after hema…

MyelofibrosisHematopoietic Cell Transplantation (HCT)

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07104799